Edition:
India

Glaukos Corp (GKOS.N)

GKOS.N on New York Stock Exchange

34.96USD
23 May 2018
Change (% chg)

$0.79 (+2.31%)
Prev Close
$34.17
Open
$34.08
Day's High
$34.97
Day's Low
$34.08
Volume
78,906
Avg. Vol
116,407
52-wk High
$44.74
52-wk Low
$23.10

Chart for

About

Glaukos Corporation is an ophthalmic medical technology company. The Company focuses on the development and commercialization of products and procedures for the treatment of glaucoma. It offers iStent, a micro-invasive glaucoma surgery (MIGS) device. The iStent is a micro-bypass stent inserted through the small corneal incision... (more)

Overall

Beta: --
Market Cap(Mil.): $1,156.64
Shares Outstanding(Mil.): 34.43
Dividend: --
Yield (%): --

Financials

BRIEF-Glaukos Q1 Loss Per Share $0.08

* GLAUKOS CORP ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS

10 May 2018

BRIEF-Glaukos Q4 Earnings Per Share $0.03

* ORATION ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

01 Mar 2018

BRIEF-Glaukos' Idose Travoprost Achieves Sustained IOP Reduction And Favorable Safety Profile In 12-Month Interim Cohort

* GLAUKOS CORPORATION’S IDOSE™ TRAVOPROST ACHIEVES SUSTAINED IOP REDUCTION AND FAVORABLE SAFETY PROFILE IN 12-MONTH INTERIM COHORT

10 Jan 2018

BRIEF-Glaukos Submits IDE Application To FDA To Study iStent Infinite Trabecular Micro-Bypass System

* GLAUKOS SUBMITS IDE APPLICATION TO FDA TO STUDY ISTENT INFINITE™ TRABECULAR MICRO-BYPASS SYSTEM

03 Jan 2018

Earnings vs. Estimates